NEW YORK, June 5, 2017 /PRNewswire/ --
Pre-market, DailyStockTracker.com monitors the performances of
select Generic Drugs stocks, namely: Innocoll Holdings PLC (NASDAQ:
INNL), Rigel Pharmaceuticals Inc. (NASDAQ: RIGL), Tetraphase
Pharmaceuticals Inc. (NASDAQ: TTPH), and Catalent Inc. (NYSE:
CTLT). According to an IBISWorld report, the Generic Pharmaceutical
Manufacturing industry is expanding rapidly. An aging population
with more chronic illnesses is driving demand for industry
products, while regulatory provisions of the Patient Protection and
Affordable Care Act expand consumer access to prescription
insurance, and provide increased opportunities for product
development. Daily Stock Tracker published free research reports on
these stocks today at:
http://dailystocktracker.com/register/
Innocoll
Athlone, Ireland headquartered
Innocoll Holdings PLC's stock saw a slight drop of 0.46%, finishing
last Friday's trading session at $2.16. A total volume of 39,515 shares was
traded. The Company's shares have gained 4.35% in the last month,
200.00% over the previous three months, and 213.04% since the start
of this year. The stock is trading above its 50-day moving average
by 12.31%. Additionally, shares of Innocoll, which manufactures and
sells collagen-based pharmaceutical products and devices in
Europe, Middle-East, Asia, and the US, have a Relative Strength
Index (RSI) of 58.60. See our free and comprehensive research
report on INNL at:
http://dailystocktracker.com/registration/?symbol=INNL
Rigel Pharma
Shares in South San Francisco,
California-based Rigel Pharmaceuticals Inc. ended at
$2.42, up 2.11% from the last trading
session. The stock recorded a trading volume of 547,554 shares. The
Company's shares have advanced 1.68% since the start of this year.
The stock is trading 14.13% below its 200-day moving average.
Moreover, shares of Rigel Pharma, which engages in the discovery
and development of drugs in the therapeutic areas of immunology,
oncology, and immuno-oncology, have an RSI of 36.48.
On June 01st, 2017,
Rigel Pharma announced that Ryan
Maynard, the Company's CFO, is scheduled to present a
company overview at the Jefferies 2017 Global Healthcare Conference
on Wednesday, June 07th,
2017, at 11:30 a.m. EDT. The
live webcast of the presentation and its subsequent archived
recording can be accessed on the Company's website. RIGL free
research report is just a click away at:
http://dailystocktracker.com/registration/?symbol=RIGL
Tetraphase Pharma
On Friday, shares in Watertown,
Massachusetts headquartered Tetraphase Pharmaceuticals Inc.
recorded a trading volume of 720,972 shares, which was above their
three months average volume of 615,800 shares. The stock jumped
6.55%, closing the day at $7.65. The
Company's shares have gained 20.66% over the previous three months
and 89.83% on an YTD basis. The stock is trading 45.23% above its
200-day moving average. Additionally, shares of Tetraphase Pharma,
which develops various antibiotics for the treatment of serious and
life-threatening multidrug-resistant infections, have an RSI of
50.87.
On May 30th, 2017,
Tetraphase Pharma announced that its management will give a
corporate presentation at the Jefferies 2017 Global Healthcare
Conference on June 07th,
2017, at 08:00 a.m. ET at the Grand
Hyatt Hotel in New York City. A
live, audio webcast of the presentation will be available on the
Company's website. Sign up for your complimentary report on
TTPH at:
http://dailystocktracker.com/registration/?symbol=TTPH
Catalent
At the close of trading on Friday, shares in Somerset, New Jersey headquartered Catalent
Inc. recorded a trading volume of 733,586 shares, which was higher
than their three months average volume of 691,010 shares. The stock
finished the session 2.03% higher at $37.12. The Company's shares have gained 28.00%
in the past month, 28.31% in the previous three months, and 37.69%
since the start of this year. The stock is trading above its 50-day
and 200-day moving averages by 21.75% and 36.80%, respectively.
Furthermore, shares of Catalent, which provides advanced delivery
technologies and development solutions for drugs, biologics, and
consumer health products worldwide, have an RSI of 79.79.
On May 25th, 2017,
Catalent announced that Matthew
Walsh, Executive Vice President and CFO, will present at the
Jefferies 2017 Healthcare Conference on June
08th, 2017, at 11:00 a.m.
EDT in New York, NY. A live
webcast of the presentation will be accessible on the Company's
website. Register for free on DailyStockTracker.com and download
the latest research report on CTLT at:
http://dailystocktracker.com/registration/?symbol=CTLT
--
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. DST has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
DST has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer") represented by a
credentialed financial analyst [for further information on analyst
credentials, please email contact@dailystocktracker.com.
Rohit Tuli, a CFA® charterholder
(the "Sponsor"), provides necessary guidance in preparing the
document templates. The Reviewer has reviewed and revised the
content, as necessary, based on publicly available information
which is believed to be reliable. Content is researched, written
and reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author
according to the procedures outlined by DST. DST is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content
outside of this document has no association with the Author or the
Reviewer in any way.
NO WARRANTY
DST, the Author, and the Reviewer are not responsible for any
error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is
accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. DST, the Author, and the
Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, DST, the Author, and the Reviewer do not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither DST nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://dailystocktracker.com/disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly.
If you're a company we are
covering and wish to no longer feature on our coverage list contact
us via email and/or phone between 09:30
EDT to 16:00 EDT
from Monday to Friday at:
Email: contact@dailystocktracker.com
Phone number: (207)-331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Chelmsford Park SA
